Dimensional Fund Advisors LP recently announced the acquisition of new stake in Ebix Inc. (NASDAQ:EBIX). The institutional investor has increased its shareholding in the Technology company by 19.85% to 1.76 million shares with purchase of 0.29 million shares. This fresh investment now brings its stake to 5.71% valued currently at $6.95 million. In addition, Millennium Management LLC raised its holdings by 1.62 million to 1.62 million shares. And SSgA Funds Management, Inc. has lifted its position by 4.21% or 42907.0 shares – to 1.06 million shares.
Currently, there are 30.82M common shares owned by the public and among those 24.25M shares have been available to trade.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Insiders at the company have transacted a total of 2 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 2 occasions, with total insider shares sold totaling 1,303 shares.
The top 3 mutual fund holders in Ebix Inc. are iShares Russell 2000 ETF, Vanguard Total Stock Market ETF, and Vanguard Small Cap Index Fund. iShares Russell 2000 ETF owns 0.86 million shares of the company’s stock, all valued at over $3.37 million. The company bought an additional 420.0 shares recently to bring their total holdings to about 2.77% of the shares outstanding. Vanguard Small Cap Index Fund bought 312.0 shares to bring its total holdings to over 0.64 million shares at a value of $2.5 million. Vanguard Small Cap Index Fund now owns shares totaling to 2.06% of the shares outstanding.
However, the script later moved the day high at 3.2700, down -67.55%. The company’s stock has a 5-day price change of -65.59% and -86.23% over the past three months. EBIX shares are trading -91.98% year to date (YTD), with the 12-month market performance down to -91.78% lower. It has a 12-month low price of $3.11 and touched a high of $32.87 over the same period. EBIX has an average intraday trading volume of 2.28 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -65.06%, -69.58%, and -89.30% respectively.
Institutional ownership of Ebix Inc. (NASDAQ: EBIX) shares accounts for 77.50% of the company’s 30.82M shares outstanding. Mutual fund holders own 40.20%, while other institutional holders and individual stakeholders account for 45.53% and 32.26% respectively.
It has a market capitalization of $49.44M and a beta (3y monthly) value of 2.50. The stock’s trailing 12-month PE ratio is 9.97, while the earnings-per-share (ttm) stands at $0.16. The company has a PEG of 1.00 and a Quick Ratio of 0.41 with the debt-to-equity ratio at 1.05. Price movements for the stock have been influenced by the stock’s volatility, which stands at 40.14% over the week and 17.58% over the month.
Analysts forecast that Ebix Inc. (EBIX) will achieve an EPS of -$0.16 for the current quarter, $0.28 for the next quarter and $0.33 for 2024. The lowest estimate earnings-per-share for the quarter is -$0.16 while analysts give the company a high EPS estimate of -$0.16. Comparatively, EPS for the current quarter was $0.26 a year ago. Earnings per share for the fiscal year are expected to decrease by -77.91%, and -84.21% over the next financial year. EPS should grow at an annualized rate of 10.00% over the next five years, compared to -7.89% over the past 5-year period.
Looking at the support for the EBIX, a number of firms have released research notes about the stock. Craig Hallum stated their Hold rating for the stock in a research note on November 09, 2023, with the firm’s price target at $5.
